Arizona State Retirement System Acquires Shares of 8,627 GRAIL, Inc. (NASDAQ:GRAL)

Arizona State Retirement System bought a new stake in GRAIL, Inc. (NASDAQ:GRAL - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 8,627 shares of the company's stock, valued at approximately $220,000.

Several other hedge funds also recently modified their holdings of GRAL. S.A. Mason LLC lifted its stake in GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after buying an additional 500 shares in the last quarter. KBC Group NV increased its holdings in shares of GRAIL by 187.7% in the first quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after purchasing an additional 933 shares during the last quarter. Caldwell Sutter Capital Inc. bought a new stake in shares of GRAIL in the first quarter valued at about $28,000. State of Tennessee Department of Treasury bought a new stake in shares of GRAIL in the fourth quarter valued at about $28,000. Finally, Sterling Capital Management LLC bought a new stake in GRAIL during the fourth quarter worth about $29,000.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group upped their price objective on shares of GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th.

Insider Activity at GRAIL

In other news, CFO Aaron Freidin sold 41,150 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,396,219.50. Following the completion of the transaction, the chief financial officer owned 294,020 shares of the company's stock, valued at $9,976,098.60. This represents a 12.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Robert P. Ragusa sold 94,035 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $3,190,607.55. Following the completion of the transaction, the chief executive officer directly owned 734,627 shares of the company's stock, valued at $24,925,894.11. This represents a 11.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 540,890 shares of company stock worth $23,868,412 over the last three months. 1.85% of the stock is owned by insiders.

GRAIL Stock Up 1.4%

Shares of GRAL stock traded up $0.57 on Friday, reaching $40.29. The company had a trading volume of 551,688 shares, compared to its average volume of 1,320,343. The stock has a market capitalization of $1.45 billion and a PE ratio of -0.66. GRAIL, Inc. has a one year low of $12.33 and a one year high of $63.99. The business's 50-day moving average is $41.84 and its 200 day moving average is $35.00.

GRAIL (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The firm had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. On average, sell-side analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.